Form 8-K - Current report:
SEC Accession No. 0001564590-19-001155
Filing Date
2019-01-25
Accepted
2019-01-25 16:15:44
Documents
4
Period of Report
2019-01-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20190125.htm 8-K 44712
2 EX-5.1 abio-ex51_29.htm EX-5.1 15303
3 EX-10.1 abio-ex101_8.htm EX-10.1 41125
4 GRAPHIC gnkjkiq1er20000001.jpg GRAPHIC 28720
  Complete submission text file 0001564590-19-001155.txt   142198
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 19542713
SIC: 2835 In Vitro & In Vivo Diagnostic Substances